Skip to main content
. 2016 Sep 1;21(35):30329. doi: 10.2807/1560-7917.ES.2016.21.35.30329

Table 1. Patient provenance, speciality and primary focus of Escherichia coli bacteraemia, England, April 2012–March 2014 (n = 66,512 patients)a.

Patient provenance n (%) Specialty n (%) Primary focus of infection n (%)
Home 50,610 (76.1) General medicine 27,254 (41.0) Genital/urinary tract 27,328 (41.1)
Nursing/residential home 5,352 (8.0) Otherb 9,525 (14.3) Unknown 11,971 (18.0)
Not known 2,051 (3.1) Surgery 8,506 (12.8) Hepatobiliary 7,611 (11.4)
Hospital (UK or abroad, incl. private) 1,380 (2.1) Care of the elderly 5,760 (8.7) Gastrointestinal (not hepatobiliary) 3,493 (5.3)
Otherc 469 (0.7) A and E 5,381 (8.1) Respiratory tract 2,065 (3.1)
PCT Hospital 156 (0.2) Urology related 2,005 (3.0) Otherd 1,932 (2.9)
Non-UK resident 117 (0.2) Oncology 1,644 (2.5) Indwelling intravascular device 828 (1.2)
Blank 6,377 (9.6) Paediatrics 1,351 (2.0) Skin/soft tissue 610 (0.9)
Not known 424 (0.6) Blank 10,674 (16.0)
Blank 4,662 (7.0)

A and E: Accident and Emergency; Incl.: including; PCT: Primary Care Trust; UK: United Kingdom.

a Of 66,512 cases of bacteraemia included in the study, information on patient provenance was available for 60,135 cases, on speciality for 61,850 and on the underlying primary focus for 55,838. Percentages in the table are based on the total of 66,512 patients.

b Specialities which were not commonly reported were grouped as ‘other’.

c Including temporary accommodation and penal establishment.

d Including: no clinical signs, bone and joint, central nervous system.